1.93 Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is definitely on the radar of hedge funds investors who own 35% of the company

<< vissza

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is definitely on the radar of hedge funds investors who own 35% of the company
Dátum: 2024-03-04 [news.yahoo.com]

A TELJES HÍR ELOLVASÁSA >>
×